{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T23:17:44Z","timestamp":1773357464069,"version":"3.50.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1097\/inf.0000000000001422","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T20:34:21Z","timestamp":1479933261000},"page":"301-306","source":"Crossref","is-referenced-by-count":13,"title":["Measles and Rubella Seroprevalence Among HIV\u2013infected and Uninfected Zambian Youth"],"prefix":"10.1097","volume":"36","author":[{"given":"Catherine G.","family":"Sutcliffe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Searle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hellen K.","family":"Matakala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle P.","family":"Greenman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlin","family":"Rainwater-Lovett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip E.","family":"Thuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R6-12-20210202","first-page":"153","article-title":"Measles outbreak\u2013California, December 2014-February 2015.","volume":"64","author":"Zipprich","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R7-12-20210202","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1093\/infdis\/jir129","article-title":"Changing epidemiology of measles in Africa.","volume":"204","author":"Goodson","year":"2011","journal-title":"J Infect Dis"},{"key":"R9-12-20210202","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/519169","article-title":"Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study.","volume":"196","author":"Moss","year":"2007","journal-title":"J Infect Dis"},{"key":"R10-12-20210202","first-page":"653","article-title":"Measles antibody in vaccinated human immunodeficiency virus type 1-infected children.","volume":"97","author":"Arpadi","year":"1996","journal-title":"Pediatrics"},{"key":"R11-12-20210202","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1086\/592756","article-title":"Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi.","volume":"198","author":"Helfand","year":"2008","journal-title":"J Infect Dis"},{"key":"R12-12-20210202","first-page":"658","article-title":"Immune responses to measles immunization and the impacts on HIV-infected children.","volume":"31","author":"Thaithumyanon","year":"2000","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"R13-12-20210202","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(04)17140-7","article-title":"Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis.","volume":"364","author":"Newell","year":"2004","journal-title":"Lancet"},{"key":"R14-12-20210202","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ije\/dyn007","article-title":"Predicted impact of the HIV-1 epidemic on measles in developing countries: results from a dynamic age-structured model.","volume":"37","author":"Scott","year":"2008","journal-title":"Int J Epidemiol"},{"key":"R16-12-20210202","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1473-3099(08)70180-4","article-title":"Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa.","volume":"8","author":"Sutcliffe","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R17-12-20210202","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1086\/648079","article-title":"Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis.","volume":"49","author":"Ciaranello","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R18-12-20210202","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/infdis\/jit404","article-title":"Changes in measles serostatus among HIV-infected Zambian children initiating antiretroviral therapy before and after the 2010 measles outbreak and supplemental immunization activities.","volume":"208","author":"Rainwater-Lovett","year":"2013","journal-title":"J Infect Dis"},{"key":"R19-12-20210202","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1473-3099(10)70116-X","article-title":"Do children infected with HIV receiving HAART need to be revaccinated?","volume":"10","author":"Sutcliffe","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R20-12-20210202","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(00)02117-6","article-title":"Immune repopulation after HAART in previously untreated HIV-1-infected children. Paediatric European Network for Treatment of AIDS (PENTA) Steering Committee.","volume":"355","author":"Gibb","year":"2000","journal-title":"Lancet"},{"key":"R21-12-20210202","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00002030-200002180-00007","article-title":"Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume.","volume":"14","author":"Vigano","year":"2000","journal-title":"AIDS"},{"key":"R22-12-20210202","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/QAI.0000000000000342","article-title":"Changes in cellular immune activation and memory T-cell subsets in HIV-infected Zambian children receiving HAART.","volume":"67","author":"Rainwater-Lovett","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R23-12-20210202","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaci.2008.04.034","article-title":"Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease.","volume":"122","author":"Moir","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"R24-12-20210202","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nri2524","article-title":"B cells in HIV infection and disease.","volume":"9","author":"Moir","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"R26-12-20210202","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/cid\/civ440","article-title":"Immunity to measles, mumps, and rubella in US children with perinatal HIV infection or perinatal HIV exposure without infection.","volume":"61","author":"Siberry","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R27-12-20210202","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/infdis\/jis386","article-title":"Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy.","volume":"206","author":"Abzug","year":"2012","journal-title":"J Infect Dis"},{"key":"R28-12-20210202","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4161\/hv.36162","article-title":"Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients.","volume":"11","author":"Sticchi","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"R29-12-20210202","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jpids\/pit054","article-title":"Susceptibility to measles among perinatally HIV-infected adolescents and young adults.","volume":"4","author":"Morris","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R30-12-20210202","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/INF.0000000000000332","article-title":"Measles seropositivity in HIV-infected Kenyan children on antiretroviral therapy.","volume":"33","author":"Newman","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R34-12-20210202","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1475-2875-10-163","article-title":"Use of remote sensing to identify spatial risk factors for malaria in a region of declining transmission: a cross-sectional and longitudinal community survey.","volume":"10","author":"Moss","year":"2011","journal-title":"Malar J"},{"key":"R35-12-20210202","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/1475-2875-10-324","article-title":"Changing individual-level risk factors for malaria with declining transmission in southern Zambia: a cross-sectional study.","volume":"10","author":"Sutcliffe","year":"2011","journal-title":"Malar J"},{"key":"R36-12-20210202","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1471-2334-9-169","article-title":"Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis.","volume":"9","author":"van Dijk","year":"2009","journal-title":"BMC Infect Dis"},{"key":"R37-12-20210202","doi-asserted-by":"crossref","first-page":"e19006","DOI":"10.1371\/journal.pone.0019006","article-title":"HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy.","volume":"6","author":"van Dijk","year":"2011","journal-title":"PLoS One"},{"key":"R38-12-20210202","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jviromet.2006.06.018","article-title":"Comparison of available methods to elute serum from dried blood spot samples for measles serology.","volume":"137","author":"Mercader","year":"2006","journal-title":"J Virol Methods"},{"key":"R39-12-20210202","doi-asserted-by":"crossref","first-page":"e1260","DOI":"10.1371\/journal.pone.0001260","article-title":"HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization.","volume":"2","author":"Tejiokem","year":"2007","journal-title":"PLoS One"},{"key":"R40-12-20210202","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/655769","article-title":"The urgent need for recommendations on revaccination of HIV-infected children after successful antiretroviral therapy.","volume":"51","author":"Rainwater-Lovett","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R41-12-20210202","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/QAD.0000000000000127","article-title":"Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy.","volume":"28","author":"Simani","year":"2014","journal-title":"AIDS"},{"key":"R42-12-20210202","doi-asserted-by":"crossref","first-page":"7939","DOI":"10.1073\/pnas.0901702106","article-title":"Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children.","volume":"106","author":"Pensieroso","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R43-12-20210202","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/1471-2458-11-327","article-title":"Seroprevalence of measles and natural rubella antibodies among children in Bangui, Central African Republic.","volume":"11","author":"Manirakiza","year":"2011","journal-title":"BMC Public Health"},{"key":"R44-12-20210202","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1017\/S0950268899003532","article-title":"Sero-epidemiology of rubella in the urban population of Addis Ababa, Ethiopia.","volume":"124","author":"Cutts","year":"2000","journal-title":"Epidemiol Infect"},{"key":"R45-12-20210202","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/1471-2458-9-269","article-title":"Rubella seroprevalence among primary and pre- primary school pupils at Moi\u2019s Bridge location, Uasin Gishu District, Kenya.","volume":"9","author":"Kombich","year":"2009","journal-title":"BMC Public Health"},{"key":"R46-12-20210202","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/JCM.33.4.811-815.1995","article-title":"Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody.","volume":"33","author":"Ratnam","year":"1995","journal-title":"J Clin Microbiol"},{"key":"R47-12-20210202","first-page":"701","article-title":"Dried venous blood samples for the detection and quantification of measles IgG using a commercial enzyme immunoassay.","volume":"81","author":"Riddell","year":"2003","journal-title":"Bull World Health Organ"},{"key":"R48-12-20210202","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0166-0934(96)02071-X","article-title":"Comparison of capillary blood versus venous blood samples in the assessment of immunity to measles.","volume":"61","author":"Novello","year":"1996","journal-title":"J Virol Methods"},{"key":"R49-12-20210202","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0166-0934(94)90052-3","article-title":"Detection of immunoglobulin G to measles virus, rubella virus, and mumps virus in serum samples and in microquantities of whole blood dried on filter paper.","volume":"49","author":"Condorelli","year":"1994","journal-title":"J Virol Methods"},{"key":"R50-12-20210202","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/jmv.24136","article-title":"Use of a commercial ELISA for the detection of measles-specific immunoglobulin G (IgG) in dried blood spots collected from children living in low-resource settings.","volume":"87","author":"Colson","year":"2015","journal-title":"J Med Virol"},{"key":"R51-12-20210202","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/jmv.2100","article-title":"Comparative detection of measles and rubella IgM and IgG derived from filter paper blood and serum samples.","volume":"65","author":"Helfand","year":"2001","journal-title":"J Med Virol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000001422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:13:09Z","timestamp":1620954789000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201703000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001422","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}